Literature DB >> 15245487

Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis.

Masanori Tachikawa1, Masahiro Fukaya, Tetsuya Terasaki, Sumio Ohtsuki, Masahiko Watanabe.   

Abstract

The creatine/phosphocreatine shuttle system, as catalysed reversibly by creatine kinases, is thought to be essential for the storing and buffering of high phosphate-bound energy in tissues with high energy demand. In the present study, we aimed to clarify the cellular system of creatine biosynthesis and its energy metabolism in the mouse brain by immunohistochemistry for creatine biosynthetic enzyme S-adenosylmethionine:guanidinoacetate N-methyltransferase (GAMT), ubiquitous mitochondrial creatine kinase (uCK-Mi) and brain-type cytoplasmic creatine kinase (CK-B). GAMT was expressed highly in oligodendrocytes and olfactory ensheathing glia and moderately in astrocytes, whereas GAMT was very low in neurons and microglia. By contrast, uCK-Mi was expressed selectively in neurons and localized in their mitochondria in dendrites, cell bodies, axons and terminals. The distinct and almost complementary distribution of GAMT and uCK-Mi suggests that the creatine in neuronal mitochondria is derived not only from the circulation, but also from local glial cells associated with these neuronal elements. By contrast, CK-B was selective to astrocytes among glial populations, and was exclusive to inhibitory neurons among neuronal populations. Interestingly, these cells with high CK-B immunoreactivity are known to be highly resistant to acute energy loss, such as hypoxia and hypoglycemia. Considering that phosphocreatine generates ATP much faster than the processes of glycolysis and oxidative phosphorylation, the highly regulated cellular expressions of creatine biosynthetic and metabolic enzymes suggest that the creatine/phosphocreatine shuttle system plays a role in brain energy homeostasis through a novel neuron-glial relationship.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15245487     DOI: 10.1111/j.1460-9568.2004.03478.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  47 in total

1.  Creatine Enhances Transdifferentiation of Bone Marrow Stromal Cell-Derived Neural Stem Cell Into GABAergic Neuron-Like Cells Characterized With Differential Gene Expression.

Authors:  Shahram Darabi; Taki Tiraihi; AliReza Delshad; Majid Sadeghizadeh; Taher Taheri; Hayder K Hassoun
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

Review 2.  White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis.

Authors:  Melissa Cambron; Miguel D'Haeseleer; Guy Laureys; Ralph Clinckers; Jan Debruyne; Jacques De Keyser
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-04       Impact factor: 6.200

3.  Cell-Type-Specific Spatiotemporal Expression of Creatine Biosynthetic Enzyme S-adenosylmethionine:guanidinoacetate N-methyltransferase in Developing Mouse Brain.

Authors:  Masanori Tachikawa; Masahiko Watanabe; Masahiro Fukaya; Kazuhisa Sakai; Tetsuya Terasaki; Ken-Ichi Hosoya
Journal:  Neurochem Res       Date:  2017-12-05       Impact factor: 3.996

Review 4.  Imaging and spectroscopic approaches to probe brain energy metabolism dysregulation in neurodegenerative diseases.

Authors:  Gilles Bonvento; Julien Valette; Julien Flament; Fanny Mochel; Emmanuel Brouillet
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-09       Impact factor: 6.200

5.  Impaired brain creatine kinase activity in Huntington's disease.

Authors:  S F Zhang; T Hennessey; L Yang; N N Starkova; M F Beal; A A Starkov
Journal:  Neurodegener Dis       Date:  2010-12-03       Impact factor: 2.977

Review 6.  The role of astrocytic glycogen in supporting the energetics of neuronal activity.

Authors:  Mauro Dinuzzo; Silvia Mangia; Bruno Maraviglia; Federico Giove
Journal:  Neurochem Res       Date:  2012-05-22       Impact factor: 3.996

Review 7.  X-linked creatine transporter deficiency: clinical aspects and pathophysiology.

Authors:  Jiddeke M van de Kamp; Grazia M Mancini; Gajja S Salomons
Journal:  J Inherit Metab Dis       Date:  2014-05-01       Impact factor: 4.982

8.  Acetate supplementation increases brain phosphocreatine and reduces AMP levels with no effect on mitochondrial biogenesis.

Authors:  Dhaval P Bhatt; Heidi M Houdek; John A Watt; Thad A Rosenberger
Journal:  Neurochem Int       Date:  2013-01-12       Impact factor: 3.921

9.  Reduced creatine kinase B activity in multiple sclerosis normal appearing white matter.

Authors:  Christel Steen; Nadine Wilczak; Johannes M Hoogduin; Marcus Koch; Jacques De Keyser
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

10.  Dissociated expression of mitochondrial and cytosolic creatine kinases in the human brain: a new perspective on the role of creatine in brain energy metabolism.

Authors:  Matthew T J Lowe; Eric H Kim; Richard L M Faull; David L Christie; Henry J Waldvogel
Journal:  J Cereb Blood Flow Metab       Date:  2013-05-29       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.